Small study aims to unravel Statins' muscle side effects
NCT ID NCT02908425
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how statins, common cholesterol-lowering drugs, affect the body's handling of a substance called HMB, which is linked to muscle health. Researchers will study 13 older adults (ages 65-80) who take statins, measuring HMB levels in blood and urine. The goal is to understand why statins can cause muscle loss and find ways to prevent it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Beta Hydroxymethyl butyrate (HMB)
- What this could lead to
- If successful, this research could point toward new ways to prevent muscle loss in older adults taking statins.
- What could go wrong
- This is a small, early-stage study with only 13 participants, focused on understanding metabolism rather than testing a treatment. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELEVATED HMB EXCRETION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas A&M University CTRAL
College Station, Texas, 77845-4253, United States